AbbVie Inc. (4AB.DE)
EUR 168.02
(0.36%)
EUR 168.02
(0.36%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 134.71 Billion USD | -2.95% |
| 2022 | 138.8 Billion USD | -5.27% |
| 2021 | 146.52 Billion USD | -2.68% |
| 2020 | 150.56 Billion USD | 68.96% |
| 2019 | 89.11 Billion USD | 50.15% |
| 2018 | 59.35 Billion USD | -16.15% |
| 2017 | 70.78 Billion USD | 7.09% |
| 2016 | 66.09 Billion USD | 24.6% |
| 2015 | 53.05 Billion USD | 92.58% |
| 2014 | 27.54 Billion USD | -5.65% |
| 2013 | 29.19 Billion USD | 8.11% |
| 2012 | 27 Billion USD | 37.4% |
| 2011 | 19.65 Billion USD | -6.99% |
| 2010 | 21.13 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 148.87 Billion USD | 10.51% |
| 2024 Q2 | 141.93 Billion USD | -4.66% |
| 2023 Q3 | 136.22 Billion USD | 0.63% |
| 2023 Q2 | 135.36 Billion USD | 0.61% |
| 2023 Q4 | 134.71 Billion USD | -1.11% |
| 2023 Q1 | 134.54 Billion USD | -3.07% |
| 2023 FY | 134.71 Billion USD | -2.95% |
| 2022 Q1 | 143.21 Billion USD | -2.26% |
| 2022 Q2 | 143.18 Billion USD | -0.02% |
| 2022 Q3 | 141.32 Billion USD | -1.3% |
| 2022 Q4 | 138.8 Billion USD | -1.78% |
| 2022 FY | 138.8 Billion USD | -5.27% |
| 2021 FY | 146.52 Billion USD | -2.68% |
| 2021 Q2 | 147.97 Billion USD | -1.68% |
| 2021 Q3 | 148.85 Billion USD | 0.6% |
| 2021 Q4 | 146.52 Billion USD | -1.56% |
| 2021 Q1 | 150.5 Billion USD | -0.04% |
| 2020 Q2 | 149.53 Billion USD | 63.96% |
| 2020 Q1 | 91.19 Billion USD | 2.34% |
| 2020 Q3 | 149.62 Billion USD | 0.06% |
| 2020 FY | 150.56 Billion USD | 68.96% |
| 2020 Q4 | 150.56 Billion USD | 0.63% |
| 2019 Q1 | 56.76 Billion USD | -4.35% |
| 2019 FY | 89.11 Billion USD | 50.15% |
| 2019 Q2 | 57.14 Billion USD | 0.66% |
| 2019 Q3 | 59.44 Billion USD | 4.02% |
| 2019 Q4 | 89.11 Billion USD | 49.92% |
| 2018 Q1 | 69.34 Billion USD | -2.04% |
| 2018 FY | 59.35 Billion USD | -16.15% |
| 2018 Q3 | 66.16 Billion USD | 7.34% |
| 2018 Q4 | 59.35 Billion USD | -10.3% |
| 2018 Q2 | 61.64 Billion USD | -11.11% |
| 2017 Q1 | 65.66 Billion USD | -0.66% |
| 2017 FY | 70.78 Billion USD | 7.09% |
| 2017 Q4 | 70.78 Billion USD | 2.83% |
| 2017 Q3 | 68.84 Billion USD | 2.76% |
| 2017 Q2 | 66.99 Billion USD | 2.03% |
| 2016 FY | 66.09 Billion USD | 24.6% |
| 2016 Q2 | 67.21 Billion USD | 25.11% |
| 2016 Q3 | 66.62 Billion USD | -0.87% |
| 2016 Q4 | 66.09 Billion USD | -0.79% |
| 2016 Q1 | 53.72 Billion USD | 1.26% |
| 2015 Q1 | 26.69 Billion USD | -3.08% |
| 2015 Q2 | 53.85 Billion USD | 101.71% |
| 2015 Q4 | 53.05 Billion USD | -3.25% |
| 2015 Q3 | 54.83 Billion USD | 1.81% |
| 2015 FY | 53.05 Billion USD | 92.58% |
| 2014 FY | 27.54 Billion USD | -5.65% |
| 2014 Q4 | 27.54 Billion USD | -3.19% |
| 2014 Q3 | 28.45 Billion USD | -2.03% |
| 2014 Q1 | 28.65 Billion USD | -1.85% |
| 2014 Q2 | 29.04 Billion USD | 1.35% |
| 2013 Q4 | 29.19 Billion USD | 3.35% |
| 2013 FY | 29.19 Billion USD | 8.11% |
| 2013 Q1 | 27.16 Billion USD | 0.6% |
| 2013 Q3 | 28.25 Billion USD | 1.23% |
| 2013 Q2 | 27.91 Billion USD | 2.73% |
| 2012 Q3 | 22.72 Billion USD | 28.35% |
| 2012 Q2 | 17.7 Billion USD | -6.6% |
| 2012 Q1 | 18.96 Billion USD | -3.54% |
| 2012 FY | 27 Billion USD | 37.4% |
| 2012 Q4 | 27 Billion USD | 18.82% |
| 2011 FY | 19.65 Billion USD | -6.99% |
| 2011 Q4 | 19.65 Billion USD | 0.0% |
| 2010 FY | 21.13 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Bayer Aktiengesellschaft | 123.34 Billion EUR | -9.216% |
| Sanofi | 126.46 Billion EUR | -6.521% |